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Abstract
Acute kidney injury (AKI) is associated with increased morbidity and mortality. Although there are many causes of
AKI, it is known that patients undergoing high-risk surgery are known to be at significant risk. Although much effort
has centred on the minimum arterial pressure needed to maintain renal perfusion, this tends to be based on
relatively crude measures such as the mean arterial pressure (MAP), which is widely used as an index for the
optimal blood pressure. The rationale behind maintaining MAP is to provide adequate organ perfusion, although
this is difficult to assess other than by applying crude end-points. Recent studies have examined the progression of
AKI as defined by the KDIGO criteria in terms of time-weighted average values for premorbid and within-ICU
haemodynamic pressure-related parameters. Although principally performed on patients who had undergone
cardiovascular surgery and who were on vasopressor support, some interesting results were obtained suggesting
that crude MAP may not be an adequate target in AKI. In patients with AKI progression, greater observed deficits in
mean perfusion pressure, diastolic arterial perfusion, and diastolic perfusion pressures were observed. This study
may highlight potential modifiable risk factors for the prevention of progression of AKI, and hopefully translate into
improved outcomes.
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The kidneys account for less than 5% of our total body
weight and yet receive about 25% of our cardiac output.
It is of no surprise, therefore, that targeting adequate
renal perfusion is considered a potential factor for modi-
fying the risk of acute kidney injury (AKI). The risk of
AKI varies depending on aetiology, but it is well estab-
lished that high-risk surgery, in particular cardiovascular
surgery, is associated with an increased threat of AKI.
Therefore, protective strategies may be instigated prior
to, or during, insult in order to minimize this potentially
devastating outcome.
The preservation or improvement of renal perfusion
may be achieved through increasing cardiac output by
fluid resuscitation, inotropic drugs, renal vasodilators, or
systemic vasopressors that all “redirect” blood flow to
the kidney. The optimal target mean arterial pressure
(MAP) remains an area of debate, although several stud-
ies have examined this including a multicentre rando-
mised controlled trial (RCT) which randomized patients
with septic shock to resuscitation with a MAP target of
either 80–85 mmHg or 65–70 mmHg [1]. This study
found no difference in mortality or renal end-points
such as the incidence of AKI stage 2 or the need for
renal replacement therapy (RRT). However, in patients
with known chronic hypertension, a higher MAP
resulted in both a lower incidence of AKI stage 2 and
less RRT but, importantly, there was no effect on mor-
tality. Lowering systolic pressure has been studied in
isolation in patients with acute cerebral haemorrhage
randomized to a systolic blood pressure target of 110–
139 mmHg or 140–179 mmHg. The primary end-point
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(death or disability) was not different between groups,
although the rate of serious renal adverse events was
higher in the lower blood pressure target group [2]. In
terms of potential treatment, norepinephrine is the most
commonly used vasopressor in patients with vasodilatory
shock although vasopressin or the analogue terlipressin
may have a role in norepinephrine refractory shock
[3, 4]. Exogenous vasopressin has vasoconstrictive and
anti-diuretic properties and may increase glomerular
filtration by preferential post-glomerular vasoconstric-
tion and hence may play a role [5].
To date, most studies have examined the MAP rather
than specific components of the derived MAP. However,
Saito and colleagues have examined patients on vaso-
pressors who had undergone cardiovascular surgery with
regard to the progression of AKI as defined by the
KDIGO criteria [6]. They measured time-weighted aver-
age values for premorbid and within-ICU haemodynamic
pressure-related parameters including systolic arterial
pressure (SAP), diastolic arterial pressure (DAP), and
MAP, and, in addition, central venous pressure (CVP; ini-
tially measured through inferior vena cava parameters
(diameter and collapse) derived from outpatient echocar-
diography examinations and subsequently from direct
measurements on the ICU). The mean perfusion pressure
(MPP) and diastolic perfusion pressure (DPP) were
calculated, with the differences between premorbid
and ICU values determined and the calculated deficits
in those values computed. This follows on from an
observational cohort study that investigated mean def-
icits between premorbid and actual mean perfusion
pressure in vasopressor-dependent ICU patients and
identified “relative hypotension”, reporting an associ-
ation between the reduced MPP and the development
of AKI [7]. Both these studies focus once again on
the pivotal role of renal blood flow in the develop-
ment of AKI under certain conditions, particularly
where renal hypoxia (at whatever level) is thought to
be significant.
When considering alterations to the systemic blood
pressure and effects on the renal circulation, however,
several features must be borne in mind. Firstly, the renal
circulation can be viewed as two circulations in series:
that to the glomerular capillaries through the afferent
arteriolar system, and that to the tubular network via the
efferent arterioles. Secondly, in order to maintain ad-
equate pressure within the glomerular and distal capil-
laries, these systems are under intimate local control.
This balance between the afferent and efferent systems,
termed auto-regulation, is a fundamental component of
renal function.
Autoregulation stabilizes renal blood flow (RBF) and
the glomerular filtration rate (GFR) during variations in
renal perfusion pressure (RPP) over a defined range,
implying that renal vascular resistance (RVR) changes in
proportion to the RPP. The major pre-glomerular resist-
ance vessels whose tone mediates most of this pressure-
induced auto-regulation includes the afferent and cor-
tical radial arteries. The efferent arterioles only play a
minor role in RBF auto-regulation, principally under
conditions of low RPP. Auto-regulation occurs through
two major mechanisms: the myogenic response and the
macula densa tubuloglomerular feedback (TGF) re-
sponse, which are outlined in Fig. 1. The myogenic
response reflects afferent arteriolar tone in response to
changes in intraluminal pressure, whereas TGF is a more
delayed response activated by tubular electrolyte delivery
and re-absorption and, as such, associates the GFR with
NaCl delivery. Consequently, TGF integrates both tubu-
lar and vascular function, and together these mecha-
nisms adjust the tone of the pre-glomerular vessels in
the face of a changing RPP. Local mediators also govern
these responses; these include angiotensin II, arachido-
nate metabolites, and NO. Thus, auto-regulation is in-
trinsic to the kidney and largely independent of extrinsic
nerves or circulating hormones [8]. Such auto-regulation
is not unique, and in many organs blood flow is regu-
lated to satisfy the metabolic demands. However, what is
different in the kidney is that the renal metabolic work
is a function of RBF and is specifically dependent on the
GFR and the amount of sodium that is to be actively
re-absorbed [9, 10]. Therefore, the higher the blood
flow the higher the metabolic demands. Given that
under normal conditions renal sympathetic tone is
low, a relatively high resting blood flow rate is ob-
served within a relatively low resistance system. Inter-
estingly, these flow waveforms observed are similar to
that seen in the brain: both a relatively high diastolic
pressure and mean flow velocity.
So, what did Saito and colleagues observe? In terms of
measured haemodynamic parameters there was no
difference in percentage SAP or MAP deficit between
the AKI+ (AKI progression group) and the AKI– (those
who did not progress). However, DAP, MPP, and
DPP were all significantly different, with the greatest
difference observed in the diastolic perfusion pres-
sure (p = 0.027, 0.023, and 0.002, respectively). The
AKI+ group had consistently greater deficits of all three
perfusion pressures in the first 24 h of vasopressor sup-
port compared with the AKI– group, with 21.7% and
23.8% of the percentage MPP and DPP deficits, respect-
ively, due to an increase in CVP, with no difference be-
tween the AKI+ and AKI– groups. Also of note is that the
median MAP of 74 was similar in both groups. Although
this study has several limitations (small sample, higher
baseline creatinine and MPP in those that progressed,
single-centre etc., all of which the authors concede to), the
results are still intriguing. The suggestion that DPP or
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indeed MPP may be viewed as haemodynamic targets in
this high-risk group would fit with the recent consensus
regarding blood pressure targets in ICU patients being
targeted to the individual, with evidence from studies in
sepsis supporting this view [11, 12].
The tailored approach to optimal blood pressure control
has some credence. A recent study using ultrasound-tagged
near infrared spectroscopy (UT-NIRS) during cardiopulmo-
nary bypass (CPB) and in the first 3 h after surgery in the
ICU examined real-time monitoring of cerebral blood flow
(CBF). This allowed derivation of the correlation flow index
(CFx) which was calculated as a moving, linear correlation
coefficient between cerebral flow index measured using
UT-NIRS and MAP [13]. This is similar to the mean
Fig. 1 Myogenic regulation is indicated by blue arrows, and the macula densa tubuloglomerular feedback response is indicated by red arrows.
Negative feedback is indicated by a red line in a black circle. ADH anti-diuretic hormone, CVP central venous pressure, GFR glomerular filtration
rate, IAP intra-abdominal pressure, RAAS renin-angiotensin-aldosterone system
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velocity index derived from transcranial Doppler [14]. Opti-
mal blood pressure was defined as the MAP with the lowest
CFx, given that when the MAP is outside the auto-
regulation range CFx becomes more positive as CBF is
dependent on changes in blood pressure. They observed
AKI in just over 27% of patients (predominantly KDIGO
1). Multivariate logistic regression for the development of
AKI showed that the blood pressure excursion below the
optimal blood pressure during CPB and in the ICU was
independently associated with CSA-AKI after adjust-
ing for possible confounding variables including total
CPB time, total cross-clamp time, pre-operative esti-
mated GFR, and surgery other than isolated coronary
artery bypass grafting (CABG).
In conclusion, we may be entering an era where the
application of non-individualised haemodynamic targets
based on empiric blood pressure may be a practice of
the past. In similar fashion to the use of intra-operative
monitoring of volume response to guide fluid therapy,
real-time monitoring of blood flow coupled with at-
tention to previously ignored parameters may well
guide intra-operative blood pressure management as
well as that on the ICU. Hopefully this will translate
to improved outcomes.
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